Back to top
more

Mesa Laboratories (MLAB)

(Real Time Quote from BATS)

$62.29 USD

62.29
135,910

+4.85 (8.44%)

Updated Aug 6, 2025 02:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (148 out of 246)

Industry: Medical - Instruments

Zacks News

Zacks Equity Research

Omnicell (OMCL) Rides on Acquisitions Amid Tough Competition

On Jul 4, we issued an updated research report on Mountain View, CA-based Omnicell Inc. (OMCL).

    Zacks Equity Research

    Abbott Freestyle Libre System Gets Health Canada License

    Abbott Laboratories (ABT) recently announced the receipt of Health Canada license for its FreeStyle Libre Flash Glucose Monitoring System.

      Zacks Equity Research

      Veeva (VEEV) Set to Grow on Subscription Revenue Focus

      On Jul 4, we issued an updated research report on Pleasanton, CA-based Veeva Systems Inc. (VEEV).

        Zacks Equity Research

        PerkinElmer (PKI) Hits a 52-Week High on Multiple Positives

        PerkinElmer Inc. (PKI) rallied to a new 52-week high of $69.19 on Jul 3, closing lower at $67.73.

          Zacks Equity Research

          Here's Why You Should Dump Quality Systems (QSII) Stock Now

          On Jul 4, we issued an updated research report on Irvine, CA-based Quality Systems Inc (QSII) -- a developer and marketer of healthcare information systems.

            Zacks Equity Research

            Varian Halcyon System Gets 510(k) Approval from the FDA

            Palo Alto, CA-based manufacturer of medical devices and software, Varian Medical Systems, Inc. (VAR) recently announced the 510(k) approval for its Halcyon system.

              Zacks Equity Research

              Can The Uptrend Continue for Mesa Laboratories (MLAB)?

              Investors certainly have to be happy with Mesa Laboratories, Inc. (MLAB) and its short term performance

                Zacks Equity Research

                Obamacare Holds Ground: 3 Medical Device Stocks to Gain

                Republican leaders have failed to play their "Trump card" this time, courtesy of the pullback of the Republican healthcare bill, the American Health Care Act (ACHA), which was designed to repeal the Affordable Care Act (ACA) or Obamacare.

                  Brian Bolan headshot

                  Five Recent Strong Buys In Two Industries

                  Over the last week two industries saw at least five stocks became Zacks Rank #1 (Strong Buy).

                    Zacks Equity Research

                    New Strong Buy Stocks for June 9th

                    Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday